How is Ehrlichiosis Treated During Pregnancy?
At a Glance
The first-line treatment for ehrlichiosis during pregnancy is a short course of the antibiotic doxycycline. Because untreated ehrlichiosis can be life-threatening, medical guidelines firmly state that the lifesaving benefits of doxycycline far outweigh the minimal risks of short-term use.
If you are pregnant and suspect you have ehrlichiosis, prompt treatment is critical. The first-line treatment for ehrlichiosis in all patients, including those who are pregnant, is an antibiotic called doxycycline [1][2][3]. While you may have read that doxycycline and other tetracycline antibiotics are generally avoided during pregnancy, doctors strongly recommend it for ehrlichiosis because the dangers of leaving the infection untreated far outweigh the risks of the medication [1][2][3].
Ehrlichiosis can quickly progress to a severe, potentially life-threatening illness if it is not treated early [4][3][5]. Severe complications can include renal failure (severe loss of kidney function), myocarditis (inflammation of the heart muscle), and sepsis (a life-threatening response to infection) [6][7][8]. While data on specific pregnancy outcomes like miscarriage are limited, a severe infection naturally compromises the mother’s body and, by extension, the environment for the baby [6][3]. Comfortingly, there are currently no documented cases of the infection being passed directly through the placenta to the fetus [9][10][11].
Because severe illness poses such a significant threat, treatment should start immediately based on clinical suspicion—such as a history of a tick bite combined with sudden fever, muscle aches, and lab changes like low platelets—rather than waiting for delayed laboratory confirmation [6][10][12].
Balancing the Risks of Doxycycline
You might feel understandably worried about taking a medication that is normally on the “do not use” list for pregnant women. Historically, older antibiotics in the tetracycline family were linked to permanent tooth staining and bone growth issues in the fetus if taken during the second or third trimesters [13][14].
However, modern medical evidence shows that short-term use of doxycycline—typically 5 to 7 days for ehrlichiosis, or until you are fever-free for a couple of days—does not pose the same risk to your baby [15][16][3]. Once you begin the medication, you will likely start to feel noticeable improvement in symptoms like fever and muscle aches within 24 to 48 hours [1][3][11]. Because ehrlichiosis can be fatal if untreated or treated too late, medical guidelines firmly establish that the lifesaving benefits of short-course doxycycline make it the safest and most appropriate choice for you and your pregnancy [1][2][3].
Alternative Treatments
In rare cases, an infectious disease specialist or maternal-fetal medicine specialist may consider alternative antibiotics if doxycycline absolutely cannot be used, such as in the case of a severe, life-threatening allergy [17][18].
The primary alternative sometimes discussed is rifampin, another type of antibiotic [17][18]. However, rifampin is not a standard or first-line recommendation for several reasons:
- Limited Evidence: There is extremely limited clinical data—mostly just single case reports—proving its effectiveness for ehrlichiosis in pregnant patients [18].
- Dosing Challenges: Pregnancy changes how your body processes medications. Studies suggest that standard doses of rifampin might lead to underdosing in pregnant individuals, which increases the risk of the treatment failing to clear the infection [19][20][21].
- Potential Complications: Rifampin carries its own risks for rare but serious complications, including acute kidney injury and hemolytic anemia (a condition where red blood cells are destroyed faster than they can be made) [22][23][24].
Ultimately, your healthcare team will carefully evaluate your specific situation, your stage of pregnancy, and the severity of your symptoms to ensure you and your baby receive the most effective and safest care possible.
Common questions in this guide
Is it safe to take doxycycline for ehrlichiosis while pregnant?
Can ehrlichiosis be passed to my baby during pregnancy?
How quickly will I feel better after starting antibiotics for ehrlichiosis?
Are there alternative treatments to doxycycline for ehrlichiosis during pregnancy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since I am taking doxycycline during pregnancy, what specific follow-up tests or extra ultrasounds will we need to monitor the baby's development?
- 2.If my fever and muscle aches don't improve within 48 hours of starting the antibiotic, what is our next step, and when should I go to the ER?
- 3.Can we review my other medications and prenatal vitamins to ensure nothing interferes with how my body absorbs the doxycycline?
- 4.Are there any specific warning signs, like changes in fetal movement or signs of preterm labor, that I should watch for during my recovery?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (24)
- 1
Ehrlichiosis-Associated Hemophagocytic Lymphohistiocytosis: A Case Series and Review of the Literature.
Hammoud K, Fulmer R, Hamner M, El Atrouni W
Case reports in hematology 2023; (2023()):5521274 doi:10.1155/2023/5521274.
PMID: 36846547 - 2
Human Monocytic Ehrlichiosis Associated With Myocarditis and Hemophagocytic Lymphohistiocytosis.
Dahm CN, Yang BQ, Clark DE, et al.
JACC. Case reports 2020; (2(3)):420-425 doi:10.1016/j.jaccas.2019.12.042.
PMID: 34317254 - 3
Assessment of Risk Factors and Outcomes of Severe Ehrlichiosis Infection.
Kuriakose K, Pettit AC, Schmitz J, et al.
JAMA network open 2020; (3(11)):e2025577 doi:10.1001/jamanetworkopen.2020.25577.
PMID: 33201233 - 4
Hemophagocytic Lymphohistiocytosis (HLH) in Patients with Tick-Borne Illness: A Scoping Review of 98 Cases.
Jevtic D, da Silva MD, Haylock AB, et al.
Infectious disease reports 2024; (16(2)):154-169 doi:10.3390/idr16020012.
PMID: 38525759 - 5
Hemophagocytic Lymphohistiocytosis Secondary to Ehrlichia Chaffeensis in Adults: A Case Series From Oklahoma.
Agudelo Higuita NI, Yuen C
The American journal of the medical sciences 2021; (361(2)):269-273 doi:10.1016/j.amjms.2020.08.029.
PMID: 32928497 - 6
Human monocytotropic ehrlichiosis-A systematic review and analysis of the literature.
Gygax L, Schudel S, Kositz C, et al.
PLoS neglected tropical diseases 2024; (18(8)):e0012377 doi:10.1371/journal.pntd.0012377.
PMID: 39093857 - 7
Myocarditis Secondary to Human Monocytotrophic Ehrlichiosis.
Kariyawasam V, Shah K
Cureus 2024; (16(4)):e59369 doi:10.7759/cureus.59369.
PMID: 38817458 - 8
Becoming Endemic: Anaplasmosis Imported Across State Borders.
Abraham JD, Wenning HS, Saeed DA, et al.
Cureus 2024; (16(4)):e57902 doi:10.7759/cureus.57902.
PMID: 38725788 - 9
National Surveillance of Human Ehrlichiosis Caused by Ehrlichia ewingii, United States, 2013-2021.
Adams SN, Bestul NC, Calloway KN, et al.
Emerging infectious diseases 2025; (31(2)):222-227 doi:10.3201/eid3102.240279.
PMID: 39983701 - 10
"Leopards do not change their spots:" tick borne disease symptomology case report.
Abernathy H, Alejo A, Arahirwa V, et al.
BMC infectious diseases 2022; (22(1)):699 doi:10.1186/s12879-022-07683-x.
PMID: 35986240 - 11
Ehrlichiosis infection mimicking thrombotic microangiopathy syndrome early after kidney transplantation.
Hassan W, Talwar M, Balaraman V, Molnar MZ
Transplant infectious disease : an official journal of the Transplantation Society 2020; (22(5)):e13305 doi:10.1111/tid.13305.
PMID: 32358827 - 12
Anaplasmosis Presenting With Respiratory Symptoms and Pneumonitis.
Rivera JE, Young K, Kwon TS, et al.
Open forum infectious diseases 2020; (7(8)):ofaa265 doi:10.1093/ofid/ofaa265.
PMID: 32793764 - 13
Urinary tetracycline antibiotics exposure during pregnancy and maternal thyroid hormone parameters: A repeated measures study.
Geng M, Gao H, Wang B, et al.
The Science of the total environment 2022; (838(Pt 2)):156146 doi:10.1016/j.scitotenv.2022.156146.
PMID: 35605876 - 14
Doxycycline and Tooth Discoloration in Children: Changing of Recommendations Based on Evidence of Safety.
Stultz JS, Eiland LS
The Annals of pharmacotherapy 2019; (53(11)):1162-1166 doi:10.1177/1060028019863796.
PMID: 31280586 - 15
Dental safety of short-term doxycycline use in children under 8 years: a systematic review and meta-analysis.
Rajan AS, Gopal M, Periyathambi M, Kuttiatt VS
Frontiers in pharmacology 2025; (16()):1646638 doi:10.3389/fphar.2025.1646638.
PMID: 41069592 - 16
Antibiotic Exposure and Dental Health: A Systematic Review.
Ravindra D, Huang G, Hallett K, et al.
Pediatrics 2023; (152(1)) doi:10.1542/peds.2023-061350.
PMID: 37264510 - 17
Experimental infection and co-infection with Chinese strains of Ehrlichia canis and Babesia vogeli in intact and splenectomized dogs: Insights on clinical, hematologic and treatment responses.
Zhang J, Wang J, Kelly PJ, et al.
Veterinary parasitology 2023; (323()):110032 doi:10.1016/j.vetpar.2023.110032.
PMID: 37783174 - 18
Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin.
Abusaada K, Ajmal S, Hughes L
Cureus 2016; (8(1)):e444 doi:10.7759/cureus.444.
PMID: 26918212 - 19
Rifampin Exposure in Pregnant and Nonpregnant Women With Tuberculosis in India.
Rao PS, Prakash Babu S, Ezhumalai K, et al.
The Journal of infectious diseases 2026; (233(3)):594-597 doi:10.1093/infdis/jiaf467.
PMID: 40925610 - 20
Pharmacokinetics of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum with and without efavirenz-based antiretroviral treatment: IMPAACT P1026s study.
Van Schalkwyk M, Bekker A, Decloedt E, et al.
Antimicrobial agents and chemotherapy 2025; (69(9)):e0005225 doi:10.1128/aac.00052-25.
PMID: 40741959 - 21
Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa.
Denti P, Martinson N, Cohn S, et al.
Antimicrobial agents and chemotherapy 2015; (60(3)):1234-41 doi:10.1128/AAC.02051-15.
PMID: 26643345 - 22
Rifampin-induced Acute Kidney Injury Is Associated With Hemolysis and Drug Re-exposure.
Wali JA, Jamal YA, Al-Kawaaz M, et al.
Kidney medicine 2026; (8(1)):101165 doi:10.1016/j.xkme.2025.101165.
PMID: 41510004 - 23
Extreme and Severe Systemic Pain Caused by Rifampicin: A Case Report of a Rare Allergic Reaction.
Li TX, Xiong YM, Gao WW, et al.
Current drug safety 2025; (20(4)):539-544 doi:10.2174/0115748863359479250121114135.
PMID: 39931993 - 24
Rifampin-induced acute kidney injury and hemolysis: A case report and literature review of a rare condition.
Ata F, Magboul HMB, Toba HAA, et al.
Clinical case reports 2022; (10(12)):e6780 doi:10.1002/ccr3.6780.
PMID: 36567686
This page provides educational information about treating ehrlichiosis during pregnancy. Always consult your obstetrician or infectious disease specialist immediately if you suspect a tick-borne illness.
Get notified when new evidence is published on Ehrlichiosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.